The impact of confounders on the test performance of natriuretic peptides for cardiac dysfunction in subjects aged 80 and older

Peptides

Volumn 38, Issue 1, 2012, Pages 118-126

  Vaes, Bert ^a   Gruson, Damien ^b   Van Pottelbergh, Gijs ^a,c   Pasquet, Agnes ^b   Matheï, Catharina ^a,c   Adriaensen, Wim ^a,c   Rezzoug, Nawel ^b   Vanoverschelde, Jean Louis ^b   Degryse, Jan ^a,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

80 and over; Aged; Cardiac dysfunction; Natriuretic peptides; Sensitivity and specificity

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYSTATIN C; NATRIURETIC FACTOR;

AGED; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PRIORITY JOURNAL; PROBABILITY; SYSTOLIC DYSFUNCTION; VALVULAR HEART DISEASE;

AGED, 80 AND OVER; ATRIAL FIBRILLATION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PACEMAKER, ARTIFICIAL; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 84866305586     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.08.020     Document Type: Article

References (34)

1. W.P. Abhayaratna, T.H. Marwick, N.G. Becker, I.M. Jeffery, D.A. McGill, and W.T. Smith Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide Am Heart J 152 2006 941 948
2. L.C. Costello-Boerrigter, G. Boerrigter, M.M. Redfield, R.J. Rodeheffer, L.H. Urban, and D.W. Mahoney Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction J Am Coll Cardiol 47 2006 345 353
3. A. Dawson, J.I. Davies, A.D. Morris, and A.D. Struthers B-type natriuretic peptide is associated with both augmentation index and left ventricular mass in diabetic patients without heart failure Am J Hypertens 18 2005 1586 1591
4. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
5. P.F. Downie, S. Talwar, I.B. Squire, J.E. Davies, D.B. Barnett, and L.L. Ng Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction Clin Sci (Lond) 97 1999 255 258
6. C.M. Fletcher Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score) BMJ 2 1960 1665
7. J.A. Hanley, and B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843
8. P. Hildebrandt, P.O. Collinson, R.N. Doughty, A. Fuat, D.C. Gaze, and F. Gustafsson Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care Eur Heart J 31 2010 1881 1889
9. R. Hoffmann, H. Lethen, T. Marwick, R. Rambaldi, P. Fioretti, and A. Pingitore Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation Am J Cardiol 82 1998 1520 1524
10. A.S. Jaffe, F.S. Apple, and L. Babuin Why we don't know the answer may be more important than the specific question Clin Chem 50 2004 1495 1497
11. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
12. T.K. Lim, H. Ashrafian, G. Dwivedi, P.O. Collinson, and R. Senior Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: implication for diagnosis of diastolic heart failure Eur J Heart Fail 8 2006 38 45
13. S. Linzbach, A. Samigullin, S. Yilmaz, M. Tsioga, A.M. Zeiher, and I. Spyridopoulos Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure Am J Cardiol 103 2009 1128 1133
14. A. Maisel, C. Mueller, K. Adams Jr., S.D. Anker, N. Aspromonte, and J.G. Cleland State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
15. T.A. McDonagh, C.E. Morrison, A. Lawrence, I. Ford, H. Tunstall-Pedoe, and J.J. McMurray Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population Lancet 350 1997 829 833
16. S. Morgan, H. Smith, I. Simpson, G.S. Liddiard, H. Raphael, and R.M. Pickering Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey BMJ 318 1999 368 372
17. A. Mosterd, and A.W. Hoes Clinical epidemiology of heart failure Heart 93 2007 1137 1146
18. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, and O.A. Smiseth Recommendations for the evaluation of left ventricular diastolic function by echocardiography Eur J Echocardiogr 10 2009 165 193
19. M.A. Quinones, C.M. Otto, M. Stoddard, A. Waggoner, and W.A. Zoghbi Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 2002 167 184
20. B.S. Rana, J.I. Davies, M.M. Band, S.D. Pringle, A. Morris, and A.D. Struthers B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes Heart 92 2006 916 920
21. I. Raymond, B.A. Groenning, P.R. Hildebrandt, J.C. Nilsson, M. Baumann, and J. Trawinski The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population Heart 89 2003 745 751
22. Report of a WHO scientific group. Nutritional anaemias World Health Organ Tech Rep Ser 405 1968 5 37
23. F.H. Rutten, D.E. Grobbee, and A.W. Hoes Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice Eur J Heart Fail 5 2003 337 344
24. M. Schou, U. Alehagen, J.P. Goetze, F. Gustafsson, and U. Dahlstrom Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals Heart 95 2009 1514 1519
25. A. Struthers, and C. Lang The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney Eur Heart J 28 2007 1678 1682
26. The SOLVD Investigattors Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
27. B. Vaes, W. de Ruijter, J. Gussekloo, and J. Degryse The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review Age Ageing 38 2009 655 662
28. B. Vaes, A. Pasquet, P. Wallemacq, N. Rezzoug, H. Mekouar, and P.A. Olivier The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium BMC Geriatr 10 2010 39
29. B. Vaes, N. Rezzoug, A. Pasquet, P. Wallemacq, G. Van Pottelbergh, and C. Mathei The prevalence of cardiac dysfunction and the correlation with poor functioning among the very elderly Int J Cardiol 155 2012 134 143
30. T.J. Wang, J.C. Evans, E.J. Benjamin, D. Levy, E.C. LeRoy, and R.S. Vasan Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
31. N.M. Wheeldon, T.M. MacDonald, C.J. Flucker, A.D. McKendrick, D.G. McDevitt, and A.D. Struthers Echocardiography in chronic heart failure in the community Q J Med 86 1993 17 23
32. K.Y. Wong, S. McSwiggan, N.S. Kennedy, R.S. MacWalter, and A.D. Struthers B-type natriuretic peptide identifies silent myocardial ischaemia in stroke survivors Heart 92 2006 487 489
33. A.H. Wu, A. Smith, S. Wieczorek, J.F. Mather, B. Duncan, and C.M. White Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure Am J Cardiol 92 2003 628 631
34. W.A. Zoghbi, M. Enriquez-Sarano, E. Foster, P.A. Grayburn, C.D. Kraft, and R.A. Levine Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802